---
title: "CHRO.US (CHRO.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CHRO.US/news.md"
symbol: "CHRO.US"
name: "CHRO.US"
parent: "https://longbridge.com/zh-CN/quote/CHRO.US.md"
datetime: "2026-03-15T12:39:07.511Z"
locales:
  - [en](https://longbridge.com/en/quote/CHRO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CHRO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CHRO.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/CHRO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CHRO.US/news.md)


# CHRO.US (CHRO.US) — 相关新闻

### [Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million | CRDL Stock News](https://longbridge.com/zh-CN/news/273526623.md)
*2026-01-23T06:16:00.000Z*
> Cardiol Therapeutics Inc. has successfully closed a private placement of units, raising gross proceeds of $14.85 million

### [Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement](https://longbridge.com/zh-CN/news/246980196.md)
*2025-07-02T11:38:04.000Z*
> The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concur

### [Why Is Channel Therapeutics Stock Surging On Friday?](https://longbridge.com/zh-CN/news/246462703.md)
*2025-06-27T16:49:00.000Z*
> Channel Therapeutics announces 10-for-1 stock split ahead of merger. Company to rebrand as Pelthos Therapeutics and chan

### [Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement](https://longbridge.com/zh-CN/news/246445817.md)
*2025-06-27T14:04:46.000Z*
> FREEHOLD, N.J., June 27, 2025 ( GLOBE NEWSWIRE ) -- Channel Therapeutics Corporation, ( "Channel" or the "Company" ) , C

### [Channel Therapeutics Corp. conducting 10-for-one stock split, merging with Pelthos Therapeutics, raising $50.1M in private placement.](https://longbridge.com/zh-CN/news/246445983.md)
*2025-06-27T14:04:34.000Z*
> Channel Therapeutics Corporation has announced a 10-for-one reverse stock split to increase its share price and meet NYS

### [EXCLUSIVE: Channel Therapeutics Touts Positive Efficacy Results For Eye Treatment Potential In Multiple Preclinical In Vivo Models](https://longbridge.com/zh-CN/news/240167216.md)
*2025-05-14T11:59:12.000Z*
> Channel Therapeutics Corporation (CHRO) announced positive efficacy results for its eye drop formulation CT2000 in two p

### [Channel Therapeutics | 10-Q: FY2025 Q1 EPS: USD -0.32](https://longbridge.com/zh-CN/news/240060340.md)
*2025-05-13T20:33:21.000Z*
### [Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules](https://longbridge.com/zh-CN/news/238497897.md)
*2025-05-01T21:33:16.000Z*
> FREEHOLD, N.J., May 01, 2025 ( GLOBE NEWSWIRE ) -- Channel Therapeutics Corporation, ( "Channel" or the "Company" ) , ( 

### [EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity](https://longbridge.com/zh-CN/news/236387790.md)
*2025-04-17T09:45:35.000Z*
> Ligand Pharmaceuticals and Channel Therapeutics have signed a merger agreement to combine their subsidiaries, Pelthos Th